Farr Miller & Washington’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $3.29M | Sell |
55,539
-701
| -1% | -$46.2K | 0.21% | 54 |
|
|
2021
Q2 | $3.76M | Buy |
56,240
+1,757
| +3% | +$115K | 0.25% | 48 |
|
|
2021
Q1 | $3.44M | Buy |
54,483
+2,891
| +6% | +$180K | 0.24% | 47 |
|
|
2020
Q4 | $3.2M | Buy |
51,592
+1,202
| +2% | +$73.9K | 0.24% | 47 |
|
|
2020
Q3 | $3.04M | Sell |
50,390
-495
| -1% | -$29.8K | 0.26% | 45 |
|
|
2020
Q2 | $2.99M | Buy |
50,885
+3,465
| +7% | +$207K | 0.24% | 45 |
|
|
2020
Q1 | $2.64M | Sell |
47,420
-531,848
| -92% | -$32.5M | 0.25% | 47 |
|
|
2019
Q4 | $37.2M | Sell |
579,268
-1,119
| -0.2% | -$64.1K | 2.69% | 17 |
|
|
2019
Q3 | $29.4M | Buy |
580,387
+1,492
| +0.3% | +$70.1K | 2.34% | 24 |
|
|
2019
Q2 | $26.3M | Sell |
578,895
-1,173
| -0.2% | -$54.6K | 2.17% | 23 |
|
|
2019
Q1 | $27.7M | Buy |
580,068
+29,981
| +5% | +$1.49M | 2.36% | 23 |
|
|
2018
Q4 | $28.6M | Sell |
550,087
-28,706
| -5% | -$1.54M | 2.72% | 14 |
|
|
2018
Q3 | $35.9M | Buy |
578,793
+198,982
| +52% | +$11.8M | 3.04% | 10 |
|
|
2018
Q2 | $21M | Sell |
379,811
-1,377
| -0.4% | -$74.4K | 1.9% | 27 |
|
|
2018
Q1 | $24.1M | Buy |
381,188
+1,180
| +0.3% | +$75.9K | 2.24% | 21 |
|
|
2017
Q4 | $23.3M | Sell |
380,008
-1,631
| -0.4% | -$102K | 2.08% | 26 |
|
|
2017
Q3 | $24.3M | Buy |
381,639
+324,976
| +574% | +$19M | 2.32% | 21 |
|
|
2017
Q2 | $3.16M | Sell |
56,663
-740
| -1% | -$40.3K | 0.31% | 44 |
|
|
2017
Q1 | $3.12M | Buy |
57,403
+1,810
| +3% | +$99.3K | 0.32% | 40 |
|
|
2016
Q4 | $3.25M | Buy |
55,593
+1,622
| +3% | +$88.7K | 0.35% | 42 |
|
|
2016
Q3 | $2.91M | Sell |
53,971
-533
| -1% | -$34.2K | 0.32% | 44 |
|
|
2016
Q2 | $4.01M | Buy |
54,504
+2,968
| +6% | +$210K | 0.45% | 37 |
|
|
2016
Q1 | $3.29M | Buy |
51,536
+2,503
| +5% | +$158K | 0.38% | 38 |
|
|
2015
Q4 | $3.37M | Buy |
49,033
+422
| +0.9% | +$27.9K | 0.4% | 38 |
|
|
2015
Q3 | $2.88M | Sell |
48,611
-3,633
| -7% | -$230K | 0.37% | 39 |
|
|
2015
Q2 | $3.48M | Buy |
52,244
+79
| +0.2% | +$5.21K | 0.4% | 37 |
|
|
2015
Q1 | $3.37M | Buy |
52,165
+200
| +0.4% | +$12.5K | 0.39% | 38 |
|
|
2014
Q4 | $3.07M | Buy |
51,965
+950
| +2% | +$53.6K | 0.36% | 39 |
|
|
2014
Q3 | $2.61M | Sell |
51,015
-2,058
| -4% | -$103K | 0.34% | 41 |
|
|
2014
Q2 | $2.58M | Buy |
53,073
+1,736
| +3% | +$85.5K | 0.33% | 44 |
|
|
2014
Q1 | $2.67M | Buy |
51,337
+990
| +2% | +$52.7K | 0.37% | 41 |
|
|
2013
Q4 | $2.68M | Sell |
50,347
-790
| -2% | -$40.2K | 0.37% | 42 |
|
|
2013
Q3 | $2.37M | Sell |
51,137
-3,115
| -6% | -$137K | 0.38% | 41 |
|
|
2013
Q2 | $2.42M | Buy |
+54,252
| New | +$2.36M | 0.4% | 42 |
|
Other funds holding BMY
Farr Miller & Washington's BMY Position: Q3 2021 in Review
Farr Miller & Washington reduced its Bristol-Myers Squibb (BMY) stake by 1.2% in Q3 2021, selling an estimated $46.2K and leaving 55,539 shares worth $3.29M. The position accounts for 0.21% of the portfolio, ranked #54.
Farr Miller & Washington first reported a position in BMY in Q2 2013 and has held it in 34 quarters since. The position peaked at $37.2M in Q4 2019. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.
- Farr Miller & Washington held 55,539 shares of Bristol-Myers Squibb worth $3.29M as of Q3 2021.
- Farr Miller & Washington sold 701 Bristol-Myers Squibb shares in Q3 2021, an estimated $46.2K.
- Bristol-Myers Squibb made up 0.21% of Farr Miller & Washington's portfolio in Q3 2021, its #54 holding.
- Farr Miller & Washington first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 34 quarters since.
- Farr Miller & Washington's Bristol-Myers Squibb position peaked at $37.2M in Q4 2019.
- 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.
Based on Farr Miller & Washington's 13F filing for Q3 2021, filed 15 Nov 2021.